Effects of ACEI/ARB or CCB use on atrial fibrillation in hypertensive patients following permanent pacemaker implantation.

Zhijie Liu,Ning Bian,Shaorong Wu,Yantao Cao,Yiting Su,Wenying Li,Hairui Li,Xianwu Lan,Can Jiang,Yiming Fan,Jun Guo,Dongdong Chen
DOI: https://doi.org/10.3389/fcvm.2023.1191539
IF: 3.6
2023-01-01
Frontiers in Cardiovascular Medicine
Abstract:For patients with PPI combined with hypertension, ACEI/ARB may be superior to CCB in selecting anti-hypertensive drugs, as ACEI/ARB further reduces the risk of NOAF. One reason for this may be that ACEI/ARB improves left atrial remodelling such as LAD better.
What problem does this paper attempt to address?